845256-59-9

Basic information

• Product Name: benzyl 3-fluoro-4-oxopiperidine-1-carboxylate
• Synonyms: BENZYL 3-FLUORO-4-OXOPIPERIDINE-1-CARBOXYLATE hydrate;Benzyl-3-fluoro-4-oxopioeridine-1-carboxylate;1-Cbz-3-fluoro-4-oxo-piperidine;3-fluoro-4-oxopiperidine-1-carboxylic acid benzyl ester;benzyl 3-fluoro-4-oxopiperidine-1-carboxylate;1-PIPERIDINECARBOXYLIC ACID, 3-FLUORO-4-OXO-, PHENYLMETHYL ESTER;3-fluoro-1-Methylpiperidin-4-one;benzyl 3-fluoro-4-o×opiperidine-1-carbo×ylate
• CAS NO: 845256-59-9
• Molecular Formula: C₁₃H₁₄FNO₃
• Molecular Weight: 251.256
• Mol File: 845256-59-9.mol
• Article Data: 26

Chemical Properties

• Boiling Point: 382.2±42.0 °C(Predicted)
• Appearance: /
• Density: 1.26±0.1 g/cm3(Predicted)
• PKA: -3.66±0.40(Predicted)
• CAS DataBase Reference: benzyl 3-fluoro-4-oxopiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 3-fluoro-4-oxopiperidine-1-carboxylate(845256-59-9)
• EPA Substance Registry System: benzyl 3-fluoro-4-oxopiperidine-1-carboxylate(845256-59-9)

Safety Data

• Hazardous Substances Data: 845256-59-9(Hazardous Substances Data)

Usage

General Description

Benzyl 3-fluoro-4-oxopiperidine-1-carboxylate is a chemical compound with the molecular formula C16H18FNO3. It is an ester derivative of piperidine-1-carboxylic acid and is composed of a piperidine ring with a fluorine atom at the 3 position and a carbonyl group at the 4 position, attached to a benzyl group. benzyl 3-fluoro-4-oxopiperidine-1-carboxylate has potential applications in pharmaceutical and agrochemical industries due to its unique chemical structure and properties. It may be used as an intermediate in the synthesis of various organic compounds or as a building block for the development of new drugs or pesticides. Additionally, it may have biological activity and could be of interest for medicinal chemistry research.

Upstream product

• 19099-93-5 benzyl 4-oxo-1-piperidinecarboxylate 
• 1147998-34-2 phenylmethyl 4-[(trimethylsilyl)oxy]-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 913574-94-4 benzyl 4-((tert-butyldimethylsilyl)oxy)-3,6-dihydropyridine-1(2H)-carboxylate 
• 355006-62-1 C₁₅H₂₀FNO₄ 
• 6099-86-1 cyclohexylmethyl chlorocarbonate 
• 1070896-59-1 3-fluoropiperidin-4-one hydrochloride 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 845256-60-2 Benzyl 3-fluoro-4-(methylamino)piperidine-1-carboxylate 
• 913574-95-5 benzyl (3R,4R)-3-fluoro-4-((4-nitrobenzoyl)oxy)piperidine-1-carboxylate 
• 1147112-66-0 benzyl (3R,4S)-3-fluoro-4-hydroxypiperidine-1-carboxylate 
• 913574-95-5 benzyl cis-3-fluoro-4-hydroxypiperidine-1-carboxylate 
• 913574-95-5 trans benzyl 3-fluoro-4-hydroxypiperidine-1-carboxylate 
• 1233932-54-1 C₁₅H₁₉FN₂O₃ 
• 1209780-78-8 benzyl (3S,4S)-3-fluoro-4-((4-nitrobenzoyl)oxy)piperidine-1-carboxylate 
• 1400707-07-4 (3R,4S)-4-cyclopropylamino-3-fluoro-piperidine-1-carboxylic acid benzyl ester 
• 1400707-06-3 (3S,4R)-4-cyclopropylamino-3-fluoro-piperidine-1-carboxylic acid benzyl ester 
• 1400708-38-4 C₂₁H₂₉FN₂O₄ 

Relevant articles and documents

NOVEL SUBSTITUTED PIPERAZINE AMIDE COMPOUNDS AS INDOLEAMINE 2, 3-DIOXYGENASE (IDO) INHIBITORS

Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

6,5-FUSED HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

The present invention is directed to 6,5-fused heteroarylpiperidine ether compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDIN-5-ONE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

The present invention is directed to 6,7-dihydro-5H-pyrrolo[3,4-b]pyridine-5-one compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.